<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bettini ML</submitter><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>717-30</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3361541</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(5)</volume><pubmed_abstract>Regulatory T (Treg) cells, driven by the Foxp3 transcription factor, are responsible for limiting autoimmunity and chronic inflammation. We showed that a well-characterized Foxp3(gfp) reporter mouse, which expresses an N-terminal GFP-Foxp3 fusion protein, is a hypomorph that causes profoundly accelerated autoimmune diabetes on a NOD background. Although natural Treg cell development and in vitro function are not markedly altered in Foxp3(gfp) NOD and C57BL/6 mice, Treg cell function in inflammatory environments was perturbed and TGF-β-induced Treg cell development was reduced. Foxp3(gfp) was unable to interact with the histone acetyltransferase Tip60, the histone deacetylase HDAC7, and the Ikaros family zinc finger 4, Eos, which led to reduced Foxp3 acetylation and enhanced K48-linked poly</pubmed_abstract><journal>Immunity</journal><pubmed_title>Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.</pubmed_title><pmcid>PMC3361541</pmcid><funding_grant_id>R01 AI039480</funding_grant_id><funding_grant_id>DK089125</funding_grant_id><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>R01 DK089125</funding_grant_id><funding_grant_id>R01 CA203689</funding_grant_id><funding_grant_id>R29 AI039480</funding_grant_id><funding_grant_id>AI039480</funding_grant_id><funding_grant_id>CA-21765</funding_grant_id><funding_grant_id>R01 AI091977</funding_grant_id><funding_grant_id>AI091977</funding_grant_id><pubmed_authors>Ziegler SF</pubmed_authors><pubmed_authors>Finkelstein D</pubmed_authors><pubmed_authors>Bettini M</pubmed_authors><pubmed_authors>Vignali DA</pubmed_authors><pubmed_authors>Pan F</pubmed_authors><pubmed_authors>Bell BD</pubmed_authors><pubmed_authors>Rehg JE</pubmed_authors><pubmed_authors>Bettini ML</pubmed_authors><pubmed_authors>Floess S</pubmed_authors><pubmed_authors>Pardoll DM</pubmed_authors><pubmed_authors>Huehn J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.</name><description>Regulatory T (Treg) cells, driven by the Foxp3 transcription factor, are responsible for limiting autoimmunity and chronic inflammation. We showed that a well-characterized Foxp3(gfp) reporter mouse, which expresses an N-terminal GFP-Foxp3 fusion protein, is a hypomorph that causes profoundly accelerated autoimmune diabetes on a NOD background. Although natural Treg cell development and in vitro function are not markedly altered in Foxp3(gfp) NOD and C57BL/6 mice, Treg cell function in inflammatory environments was perturbed and TGF-β-induced Treg cell development was reduced. Foxp3(gfp) was unable to interact with the histone acetyltransferase Tip60, the histone deacetylase HDAC7, and the Ikaros family zinc finger 4, Eos, which led to reduced Foxp3 acetylation and enhanced K48-linked poly</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 May</publication><modification>2025-04-19T17:06:02.094Z</modification><creation>2019-03-27T00:53:56Z</creation></dates><accession>S-EPMC3361541</accession><cross_references><pubmed>22579476</pubmed><doi>10.1016/j.immuni.2012.03.020</doi></cross_references></HashMap>